Cargando…

Evidence of Compromised Blood-Spinal Cord Barrier in Early and Late Symptomatic SOD1 Mice Modeling ALS

BACKGROUND: The blood-brain barrier (BBB), blood-spinal cord barrier (BSCB), and blood-cerebrospinal fluid barrier (BCSFB) control cerebral/spinal cord homeostasis by selective transport of molecules and cells from the systemic compartment. In the spinal cord and brain of both ALS patients and anima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garbuzova-Davis, Svitlana, Saporta, Samuel, Haller, Edward, Kolomey, Irina, Bennett, Steven P., Potter, Huntington, Sanberg, Paul R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2075163/ https://www.ncbi.nlm.nih.gov/pubmed/18030339 http://dx.doi.org/10.1371/journal.pone.0001205

Ejemplares similares

Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier
por: Eve, David J., et al.
Publicado: (2018)

Blood-CNS Barrier Impairment in ALS patients versus an animal model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2014)

Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2017)

Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases
por: Ehrhart, Jared, et al.
Publicado: (2018)

Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2019)

Blood-brain barrier impairment in MPS III patients
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2013)

Beneficial Effects of Transplanted Human Bone Marrow Endothelial Progenitors on Functional and Cellular Components of Blood-Spinal Cord Barrier in ALS Mice
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2021)

Blood-Brain Barrier Impairment in an Animal Model of MPS III B
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2011)

Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2008)

Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2018)

Multiple Intravenous Administrations of Human Umbilical Cord Blood Cells Benefit in a Mouse Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2012)

Advancing Stem Cell Therapy for Repair of Damaged Lung Microvasculature in Amyotrophic Lateral Sclerosis
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2020)

Blood-Brain Barrier Alterations Provide Evidence of Subacute Diaschisis in an Ischemic Stroke Rat Model
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2013)

Stem cell-derived extracellular vesicles as potential mechanism for repair of microvascular damage within and outside of the central nervous system in amyotrophic lateral sclerosis: perspective schema
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2020)

Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells
por: Pokrishevsky, Edward, et al.
Publicado: (2017)

Bradykinin and noradrenaline preconditioning influences level of antioxidant enzymes SOD, CuZn-SOD, Mn-SOD and catalase in the white matter of spinal cord in rabbits after ischemia/reperfusion
por: Danková, Marianna, et al.
Publicado: (2019)

Extracellular vesicle-based therapy for amyotrophic lateral sclerosis
por: Sadanandan, Nadia, et al.
Publicado: (2021)

Patching Up the Permeability: The Role of Stem Cells in Lessening Neurovascular Damage in Amyotrophic Lateral Sclerosis
por: Monsour, Molly, et al.
Publicado: (2022)

Histopathological changes of the spinal cord and motor neuron dynamics in SOD1 Tg mice
por: Tanaka, Masaharu, et al.
Publicado: (2021)

Posterior spinal decompression in adults with spinal cord injury without traumatic compromise of the spinal canal: what is the data?
por: Solou, Mary, et al.
Publicado: (2023)

S-acylation of SOD1, CCS, and a stable SOD1-CCS heterodimer in human spinal cords from ALS and non-ALS subjects
por: Antinone, Sarah E., et al.
Publicado: (2017)

Apolipoprotein A1 Enhances Endothelial Cell Survival in an In Vitro Model of ALS
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2022)

Cytoplasmic Restriction of Mutated SOD1 Impairs the DNA Repair Process in Spinal Cord Neurons
por: Li, Jiaojie, et al.
Publicado: (2019)

Neuronal–glial communication perturbations in murine SOD1(G93A) spinal cord
por: MacLean, Michael, et al.
Publicado: (2022)

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord
por: Trist, Benjamin G, et al.
Publicado: (2022)

The human G93A-SOD1 mutation in a pre-symptomatic rat model of amyotrophic lateral sclerosis increases the vulnerability to a mild spinal cord compression
por: Jokic, Natasa, et al.
Publicado: (2010)

Compromised T-cell immunity in patients with spinal cord injury and its relationship with injury characteristics
por: Kartal, Ozgur, et al.
Publicado: (2022)

Humoral factors in ALS patients during disease progression
por: Ehrhart, Jared, et al.
Publicado: (2015)

Predictors of symptomatic myelopathy in degenerative cervical spinal cord compression
por: Kadanka, Zdenek, et al.
Publicado: (2017)

Spontaneous Regression of a Symptomatic Intramedullary Spinal Cord Lesion
por: Mikula, Anthony, et al.
Publicado: (2020)

Carbonic Anhydrase I Is Recognized by an SOD1 Antibody upon Biotinylation of Human Spinal Cord Extracts
por: Liu, Jian, et al.
Publicado: (2010)

Microsurgical resection of symptomatic intramedullary cervical spinal cord cavernous malformation
por: Dziedzic, Tomasz A., et al.
Publicado: (2019)

Reduction of Circulating Endothelial Cells in Peripheral Blood of ALS Patients
por: Garbuzova-Davis, Svitlana, et al.
Publicado: (2010)

Cu(II)(atsm) improves the neurological phenotype and survival of SOD1(G93A) mice and selectively increases enzymatically active SOD1 in the spinal cord
por: Hilton, James B., et al.
Publicado: (2017)

RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse
por: Bandyopadhyay, Urmi, et al.
Publicado: (2013)

Gamisoyo-San Ameliorates Neuroinflammation in the Spinal Cord of hSOD1(G93A) Transgenic Mice
por: Cai, MuDan, et al.
Publicado: (2018)

Metabolic and Stress Response Changes Precede Disease Onset in the Spinal Cord of Mutant SOD1 ALS Mice
por: Pharaoh, Gavin, et al.
Publicado: (2019)

The Compromised Intestinal Barrier Induced by Mycotoxins
por: Gao, Yanan, et al.
Publicado: (2020)

Symptomatic malignant spinal cord compression in children: a single-center experience
por: De Martino, Lucia, et al.
Publicado: (2019)

Moderate systemic therapeutic hypothermia is insufficient to protect blood-spinal cord barrier in spinal cord injury
por: Zhou, Rubing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j1fdss6hp4h2bfgnrtv9k2r5l8